Live Breaking News & Updates on Silence therapeutics

Stay informed with the latest breaking news from Silence therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Silence therapeutics and stay connected to the pulse of your community

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,...

Hansoh-pharma , Nasdaq , Astrazeneca , Silence-therapeutics , Annual-bioconnect-investor-conference , Markets ,

Silence Therapeutics (SLN) Announces Retirement of Alistair Gray from Board of Directors

Silence Therapeutics (SLN) Announces Retirement of Alistair Gray from Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-jersey , United-states , Berlin , Germany , London , City-of , United-kingdom , Iain-ross , Alistair-gray , Craig-tooman , Nasdaq , Silence-therapeutics

Morgan Stanley Reiterates "Overweight" Rating for Silence Therapeutics (NASDAQ:SLN)

Morgan Stanley Reiterates "Overweight" Rating for Silence Therapeutics (NASDAQ:SLN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Parkman-healthcare-partners , Vivo-capital , Morgan-stanley , Sg-americas-securities , Silence-therapeutics , Free-report , Therapeutics-trading-down , Get-free-report , Healthcare-partners , Oligonucleotide-discovery , Silence-therapeutics-daily

Silence Therapeutics (LON:SLN) Stock Price Crosses Below 200 Day Moving Average of $535.00

Silence Therapeutics plc (LON:SLN – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 535 ($6.66) and traded as low as GBX 512 ($6.37). Silence Therapeutics shares last traded at GBX 535 ($6.66), with a volume of 913,528 shares trading hands. […]

Silence-therapeutics , Get-free-report , Oligonucleotide-discovery , Silence-therapeutics-daily , Lon-sln , Sln , Medical , Stocks , Technicals ,

Short Interest in Silence Therapeutics plc (NASDAQ:SLN) Rises By 74.8%

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 162,000 shares, an increase of 74.8% from the March 15th total of 92,700 shares. Based on an average trading volume of 241,700 shares, the short-interest ratio […]

Nasdaq , Parkman-healthcare-partners , Goldman-sachs-group-inc , Silence-therapeutics-company-profile , Morgan-stanley , Vivo-capital , Silence-therapeutics , Get-free-report , Sachs-group , Healthcare-partners , Therapeutics-trading-down

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

Vipin-garg , Morgan-stanley , Drug-administration , Fortress-biotech , Journey-medical , New-drug-application , Prescription-drug-user-fee-act , Priority-review-vouchers , Silence-therapeutics , Chardan-capital ,

Extended Zerlasiran Data Show Sustained Lp(a) Reduction

The experimental siRNA agent led to prolonged Lp(a) reduction of more than 90%, extended data from the phase 1 trial show, supporting the move to phases 2 and 3 trials.

New-york , United-states , Cleveland , Ohio , Stevene-nissen , Roberts-rosenson , Icahn-school-of-medicine-at-mount-sinai , Cleveland-clinic , Silence-therapeutics , Icahn-school , Mount-sinai

Head to Head Review: Silence Therapeutics (OTCMKTS:SLNCF) vs. Bellerophon Therapeutics (NASDAQ:BLPH)

Silence Therapeutics (OTCMKTS:SLNCF – Get Free Report) and Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 7.9% of Silence Therapeutics […]

New-jersey , United-states , London , City-of , United-kingdom , Mallinckrodt-pharma , Ikaria-development , Hansoh-pharmaceutical-group-company , Bellerophon-therapeutics-inc , Silence-therapeutics , Get-free-report , Bellerophon-therapeutics

Head to Head Survey: Silence Therapeutics (OTCMKTS:SLNCF) vs. Bellerophon Therapeutics (NASDAQ:BLPH)

Head to Head Survey: Silence Therapeutics (OTCMKTS:SLNCF) vs. Bellerophon Therapeutics (NASDAQ:BLPH)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New-jersey , United-states , United-kingdom , London , City-of , Mallinckrodt-pharma , Ikaria-development , Hansoh-pharmaceutical-group-company , Bellerophon-therapeutics-inc , Silence-therapeutics , Get-free-report , Bellerophon-therapeutics

London markets are broken and closed, says pharma boss

A British pharmaceuticals company has criticised London’s stock markets for being “completely broken and closed” after announcing plans to de-list and pursue a potential flotation in New York.

New-york , United-states , United-kingdom , Denmark , London , City-of , British , Danish , Ali-mortazavi , Wael-sawan , Redx-pharma , Twitter